BUY Piramal Pharma Limited — Madhu Bansal
byMadhu BansalHorizon: NA (inferred Swing (≤2wk))30 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·6 Aug · 3d ago
Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
NewsGoogle News·4 Aug · 5d ago
Piramal Pharma Limited Expands Peptide API Facility with Advanced Spray Drying Suite
NewsGoogle News·4 Aug · 5d ago
Piramal Pharma Restarts Operations At Ahmedabad Units After Flood Interruption
NewsGoogle News·3 Aug · 6d ago
Piramal Pharma Limited (NSE:PPLPHARMA) Just Reported And Analysts Have Been Lifting Their Price Targets
NewsGoogle News·3 Aug · 1w ago
Buy, Sell Or Hold: Mahindra & Mahindra, UltraTech Cement, Piramal Pharma, Groww And Swiggy — Ask Profit
NewsNdtv-Profit·30 Jul · 1w ago
Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·29 Jul · 2w ago
Piramal Pharma temporarily suspends Ahmedabad plant operations due to heavy rainfall
NewsCnbc-Tv18·25 Jul · 2w ago
Piramal Pharma, Authum Investment, Vaibhav Global Show Technical Breakouts
NewsGoogle News·20 Jul · 3w ago
HDFC Mutual Fund reduces stake in Piramal Pharma by 2.005%
NewsGoogle News·18 Jul · 3w ago
HDFC Mutual Fund Sells 2% Stake in Piramal Pharma
NewsGoogle News·17 Jul · 3w ago
HDFC Mutual Fund ने Piramal Pharma मधील हिस्सा विकला, मोठी घट!
NewsGoogle News·17 Jul · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Piramal Pharma
- BUY — Nirav Chheda, Nirmal Bang Securities24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Rakesh Bansal24 Sept 2026 · Same day · target ₹219 · SL hit
- BUY — Goldman Sachs24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Sacchitanand Uttekar, Tradebulls Securities22 Sept 2026 · ~3 months · target ₹230 · SL hit
- BUY — Siddharth Rai Mangala21 Sept 2026 · ~2 weeks · target ₹230 · SL hit
More from Madhu Bansal
- BUY Supriya Lifescience29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY Supreme Petrochem29 Sept 2026 · ~2 weeks · target ₹957 · SL hit
- BUY Poonawalla Fincorp18 Sept 2026 · ~2 weeks · target ₹486 · Target hit
- BUY Prudent Corporate Advisory Services18 Sept 2026 · ~3 months · target ₹3,762 · SL hit
- BUY Sun Pharma Advanced Research Company17 Sept 2026 · ~2 weeks · target ₹208 · Target hit

